Preoperative c-reactive protein predicts long-term mortality and hospital length of stay after primary, nonemergent coronary artery bypass grafting

Anesthesiology

Volumn 112, Issue 3, 2010, Pages 607-613

  Perry, Tjörvi E ^a   Muehlschlegel, Jochen D ^a   Liu, Kuang Yu ^a   Fox, Amanda A ^a   Collard, Charles D ^a   Body, Simon C ^a   Shernan, Stanton K ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; PREOPERATIVE CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURGICAL PATIENT;

EID: 77649120039     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0b013e3181cea3b5     Document Type: Article

References (28)

1. Ridker PM: Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107:363-369
2. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, Hutchinson WL, Pepys MB: C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 1999; 99:237-242
3. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98:731-733
4. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group Fragmin during instability in coronary artery disease. N Engl J Med 2000; 343:1139-1147
5. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi AG, Pepys MB, Maseri A: The prognostic value of C-reac-tive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331:417-424
6. Cappabianca G, Paparella D, Visicchio G, Capone G, Lio-netti G, Numis F, Ferrara P, D'Agostino C, de Luca Tupputi Schinosa L: Preoperative C-reactive protein predicts midterm outcome after cardiac surgery. Ann Thorac Surg 2006; 82:2170-2178
7. Kangasniemi OP, Biancari F, Luukkonen J, Vuorisalo S, Satta J, Pokela R, Juvonen T: Preoperative C-reactive protein is predictive of long-term outcome after coronary artery bypass surgery. Eur J Cardiothorac Surg 2006; 29: 983-985
8. Palmerini T, Marzocchi A, Marrozzini C, Reggiani LB, Savini C, Marinelli G, Di Bartolomeo R, Branzi A: Preoper-ative C-reactive protein levels predict 9-month mortality after coronary artery bypass grafting surgery for the treatment of left main coronary artery stenosis. Eur J Cardio-thorac Surg 2007; 31:685-690
9. Pan W, Pintar T, Anton J, Lee VV, Vaughn WK, Collard CD: Statins are associated with a reduced incidence of periop-erative mortality after coronary artery bypass graft surgery. Circulation 2004; 110:II45-9
10. Collard CD, Body SC, Shernan SK, Wang S, Mangano DT: Preoperative statin therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2006; 132:392-400
11. Muehlschlegel JD, Perry TE, Liu KY, Nascimben L, Fox AA, Collard CD, Avery EG, Aranki SF, D'Ambra MN, Shernan SK, Body SC: Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J 2009; 30:1574-1583
12. Cox DR: Regression models and life-tables. J R Stat Soc Ser B 1972; 34:187-220
13. Ridker PM, Stampfer MJ, Rifai N: Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001; 285:2481-2485
14. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E: C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1998; 31:1460-1465 (Pubitemid 28273285)
15. Benamer H, Steg PG, Benessiano J, Vicaut E, Gaultier CJ, Boccara A, Aubry P, Nicaise P, Brochet E, Juliard JM, Himbert D, Assayag P: Comparison of the prognostic value of C-reactive protein and troponin I in patients with unstable angina pectoris. Am J Cardiol 1998; 82:845-850
16. Liakopoulos OJ, Choi YH, Haldenwang PL, Strauch J, Wit-twer T, Dorge H, Stamm C, Wassmer G, Wahlers T: Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30,000 patients. Eur Heart J 2008; 29: 1548-1559
17. Clark LL, Ikonomidis JS, Crawford FA Jr, Crumbley A III, Kratz JM, Stroud MR, Woolson RF, Bruce JJ, Nicholas JS, Lackland DT, Zile MR, Spinale FG: Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: An 8-year retrospective cohort study. J Thorac Car-diovasc Surg 2006; 131:679-685
18. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, Mac-Fadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359:2195-2207
19. Ockene IS, Matthews CE, Rifai N, Ridker PM, Reed G, Stanek E: Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem 2001; 47:444-450
20. Ridker PM, Rifai N, Pfeffer MA, Sacks F, Braunwald E: Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999; 100:230-235
21. Zwaka TP, Hombach V, Torzewski J: C-reactive protein-mediated low density lipoprotein uptake by macrophages: Implications for atherosclerosis. Circulation 2001; 103: 1194-1197
22. Pasceri V, Willerson JT, Yeh ET: Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-2168
23. Yasojima K, Schwab C, McGeer EG, McGeer PL: Generation of C-reactive protein and complement components in atherosclerotic plaques. Am J Pathol 2001; 158:1039-1051 (Pubitemid 32221796)
24. Pepys MB, Hawkins PN, Kahan MC, Tennent GA, Galli-more JR, Graham D, Sabin CA, Zychlinsky A, de Diego J: Proinflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products, not by C-reactive protein itself. Circ Res 2005; 97:e97-103
25. Taylor KE, Giddings JC, van den Berg CW: C-reactive protein-induced in vitro endothelial cell activation is an artifact caused by azide and lipopolysaccharide. Arterio-scler Thromb Vasc Biol 2005; 25:1225-1230
26. Zee RY, Ridker PM: Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis 2002; 162:217-219
27. Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, Cook NR, Ridker PM, Kwiatkowski DJ: Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 2005; 69:623-638
28. Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witte-man JC: C-reactive protein gene haplotypes and risk of coronary heart disease: The Rotterdam Study. Eur Heart J 2006; 27:1331-1337 (Pubitemid 43998108)